Metformin and epithelial ovarian cancer therapeutics

被引:0
作者
Seema Patel
Lalit Kumar
Neeta Singh
机构
[1] All India Institute of Medical Science (AIIMS),Department of Biochemistry
[2] AIIMS,Institute of Rotary and Cancer Hospital (IRCH)
来源
Cellular Oncology | 2015年 / 38卷
关键词
Metformin; Ovarian cancer; Apoptosis; Bcl-2;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:365 / 375
页数:10
相关论文
共 242 条
[1]  
Chien JR(2007)Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer J. Cell. Biochem. 102 1117-1129
[2]  
Aletti G(2014)2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) inhibits human ovarian cancer cell proliferation Cell. Oncol. 37 429-437
[3]  
Bell DA(2014)Expression of H1.5 and PLZF in granulosa cell tumors and normal ovarian tissues: a short report Cell. Oncol. 37 229-234
[4]  
Keeney GL(2013)The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients Cell. Oncol. 36 363-374
[5]  
Shridhar V(2009)Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro Cell Cycle 8 909-915
[6]  
Hartmann LC(2006)Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells Cancer Res. 66 10269-10273
[7]  
Li Y(2001)Role of AMP-activated protein kinase in mechanism of metformin action J. Clin. Invest. 108 1167-1174
[8]  
Wang K(2006)Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin Diabetes Care 29 254-258
[9]  
Jiang Y-Z(2010)Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16 Diabetes Care 33 322-326
[10]  
Chang X-W(2009)New users of metformin are at low risk of incident cancer A cohort study among people with type 2 diabetes Diabetes Care 32 1620-1625